Welcome to our dedicated page for Procept Biorobotics SEC filings (Ticker: PRCT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The PROCEPT BioRobotics Corporation (PRCT) SEC filings page on Stock Titan provides access to the company’s official regulatory disclosures filed with the U.S. Securities and Exchange Commission. PROCEPT BioRobotics is a surgical robotics company in urology, listed on The Nasdaq Global Market under the symbol PRCT, and its filings offer detailed information on business operations, financial performance, risk factors, and governance.
Investors can review annual reports on Form 10-K and quarterly reports on Form 10-Q for discussions of revenue from AQUABEAM and HYDROS Robotic Systems, segment details such as U.S. and international revenue, gross margins, operating expenses, and liquidity. Current reports on Form 8-K include items such as quarterly financial results, changes to executive compensation arrangements, and other material events affecting the company.
Through this page, users can also track executive and director compensation arrangements and changes to severance or change-of-control agreements, as disclosed in 8-K exhibits. While insider transaction reports on Form 4 are not listed in the excerpts above, Stock Titan’s filings interface is designed to surface such ownership changes when available, alongside 10-K, 10-Q, and 8-K filings.
Stock Titan enhances these documents with AI-powered summaries that explain key points from lengthy filings, helping readers quickly understand topics such as revenue trends, installed base growth, non-GAAP measures like Adjusted EBITDA, and risk factor highlights. Real-time updates from the SEC’s EDGAR system ensure that new PRCT filings appear promptly, allowing investors, analysts, and researchers to follow PROCEPT BioRobotics’ regulatory and financial reporting history in one place.